INVO NASDAQ
INVO Bioscience, Inc.
1W: -6.7%
1M: -5.4%
3M: -1.0%
1Y: -57.5%
3Y: -98.8%
$0.83
Last traded 2024-11-18 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$3.3M
52W Range0.63-3.5
Volume124,018
Avg Volume1,176,580
Beta1.44
Dividend—
Analyst Ratings
Company Info
CEOSteven M. Shum
Employees25
SectorHealthcare
IndustryMedical - Devices
IPO Date2020-11-02
Websiteinvofertility.com
5582 Broadcast Court
Sarasota, FL 34240
US
Sarasota, FL 34240
US
978 878 9505
About INVO Bioscience, Inc.
INVO Bioscience, Inc. is a globally operating, commercial-phase enterprise focused on fertility, offering advanced solutions in assisted reproductive technology. Their leading product is the INVOcell, an innovative medical device engineered to allow fertilization and the initial development of embryos to naturally occur inside the woman's body. The company, headquartered in Sarasota, Florida, began its operations in 2007.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Szot Matthew K | A-Award | 85,000 | $0.37 | 2023-05-18 |
| Shum Steve | A-Award | 100,000 | $0.37 | 2023-05-18 |
| Ryan Barbara | A-Award | 85,000 | $0.37 | 2023-05-18 |
| Messina Rebecca | A-Award | 85,000 | $0.36 | 2023-05-18 |
| Goren Andrea | A-Award | 81,000 | $0.37 | 2023-05-18 |